Gilead Sciences, Inc. (GILD) operating KPIs
GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)
Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%
Gilead Sciences accumulated depreciation ($M) ($M)
Form 10-Q / 10-K Note 8 Property, Plant and Equipment
Latest, Q2 2026
2,874
Period ended Jun 30, 2026
Change on a year earlier
+9.7%
2,621 in Q2 2025
History
17 quarters
Since Q4 2014
Sources
15
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Accumulated depreciation ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 2,874 | +9.7% | Form 10-Q (filed 2026-08-06) ↗ |
| Q1 2026 | Mar 31, 2026 | 2,784 | +9.5% | Form 10-Q (filed 2026-05-07) ↗ |
| Q4 2025 | Dec 31, 2025 | 2,696 | +9.1% | Form 10-Q (filed 2026-08-06) ↗ |
| Q3 2025 | Sep 30, 2025 | 2,693 | – | Form 10-Q (filed 2025-11-07) ↗ |
| Q2 2025 | Jun 30, 2025 | 2,621 | – | Form 10-Q (filed 2025-08-07) ↗ |
| Q1 2025 | Mar 31, 2025 | 2,542 | – | Form 10-Q (filed 2025-05-07) ↗ |
| Q4 2024 | Dec 31, 2024 | 2,470 | +0.9% | Form 10-K (filed 2026-02-24) ↗ |
| Q4 2023 | Dec 31, 2023 | 2,449 | +12.0% | Form 10-K (filed 2025-02-28) ↗ |
| Q4 2022 | Dec 31, 2022 | 2,186 | +15.5% | Form 10-K (filed 2024-02-23) ↗ |
| Q4 2021 | Dec 31, 2021 | 1,893 | +13.5% | Form 10-K (filed 2023-02-22) ↗ |
| Q4 2020 | Dec 31, 2020 | 1,668 | +17.3% | Form 10-K (filed 2022-02-23) ↗ |
| Q4 2019 | Dec 31, 2019 | 1,422 | +19.4% | Form 10-K (filed 2021-02-25) ↗ |
| Q4 2018 | Dec 31, 2018 | 1,191 | +19.8% | Form 10-K (filed 2019-02-26) ↗ |
| Q4 2017 | Dec 31, 2017 | 994 | +21.5% | Form 10-K (filed 2019-02-26) ↗ |
| Q4 2016 | Dec 31, 2016 | 818 | +7.2% | Form 10-K (filed 2018-02-27) ↗ |
| Q4 2015 | Dec 31, 2015 | 763 | +23.1% | Form 10-K (filed 2017-02-27) ↗ |
| Q4 2014 | Dec 31, 2014 | 620 | – | Form 10-K (filed 2016-02-24) ↗ |
Cite this data
StockData. (2026). Gilead Sciences Accumulated depreciation ($M) ($M), quarterly Q4 2014–Q2 2026 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/ppe_accum_depr
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.